Stockwatch

NeutriSci International Inc
Symbol	NU
Shares Issued	178,424,267
Close 2023-10-11	C$ 0.005
Market Cap	C$ 892,121
Recent Sedar+ Documents

NeutriSci International appoints Ackerman as director

2023-10-20 15:54 ET - News Release

Subject: NeutriSci press release for immediate release Word Document File: '\\swfile\EmailIn\20231020 124214 Attachment NeutriSci Board Changes (10-20-23).docx' NEUTRISCI ANNOUNCES BOARD OF DIRECTOR CHANGES Vancouver, British Columbia - October 20, 2023 - NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, FRANKFURT: 1N9), an innovative technology company developing products, licencing, IP and technology for B2B partnerships and the nutraceutical industry, announces that Scott Ackerman has been appointed as a director of the Company. The Company also announces that Jeff Durno and Dana Montenegro have resigned as directors of the Company. The Company wishes to thank Mr. Durno and Mr. Montenegro for their years of service to the Company. About NeutriSci International Inc. NeutriSci specializes in the innovation, production, and formulation of nutraceutical products. Established in 2009, NeutriSci's is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for its products offering co-branding as well as private label opportunities and contract manufacturing services. For more information, please visit: www.neutrisci.com. On Behalf of the Board of Directors of NEUTRISCI INTERNATIONAL INC. Robert Chisholm CFO Tel: (778) 331-8505 For investor inquiries, please contact investors@neutrisci.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. PDF Document File: Attachment NeutriSci Board Changes (10-20-23).pdf NEUTRISCI ANNOUNCES BOARD OF DIRECTOR CHANGES Vancouver, British Columbia October 20, 2023 NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, FRANKFURT: 1N9), an innovative technology company developing products, licencing, IP and technology for B2B partnerships and the nutraceutical industry, announces that Scott Ackerman has been appointed as a director of the Company. The Company also announces that Jeff Durno and Dana Montenegro have resigned as directors of the Company. The Company wishes to thank Mr. Durno and Mr. Montenegro for their years of service to the Company. About NeutriSci International Inc. NeutriSci specializes in the innovation, production, and formulation of nutraceutical products. Established in 2009, NeutriSci's is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for its products offering co-branding as well as private label opportunities and contract manufacturing services. For more information, please visit: www.neutrisci.com. On Behalf of the Board of Directors of NEUTRISCI INTERNATIONAL INC. Robert Chisholm CFO Tel: (778) 331-8505 For investor inquiries, please contact investors@neutrisci.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward- looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.